TPTX - Turning Point Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $38.76. This is a potential upside of $38.76 (0%) from yesterday's end of day stock price of $0.

Turning Point Therapeutics's activity chart (see below) currently has 99 price targets and 62 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.39% with an average time for these price targets to be met of 77.08 days.

Most recent stock forecast was given by ANDREW BERENS from LEERINK on 13-Jun-2022.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 13-Jun-2022

$76

$-0.01 (-0.01%)

$101

3 years 6 months 28 days ago
(13-Jun-2022)

3/4 (75%)

$1.72 (2.32%)

29

Hold

Since 06-Jun-2022

$76

$-0.01 (-0.01%)

3 years 7 months 4 days ago
(06-Jun-2022)

4/6 (66.67%)

$1.25 (1.67%)

64

Hold

Since 03-Jun-2022

$76

$-0.01 (-0.01%)

$61

3 years 7 months 7 days ago
(03-Jun-2022)

4/5 (80%)

$1.41 (1.89%)

73

Hold

Since 29-Sep-2021

$45

$-31.01 (-40.80%)

$75

3 years 10 months 9 days ago
(01-Mar-2022)

2/2 (100%)

$14.21 (46.15%)

180

Buy

Since 13-May-2019

$85

$8.99 (11.83%)

$120

3 years 11 months ago
(10-Feb-2022)

4/6 (66.67%)

$49.25 (137.76%)

99

Show more analysts

Please expand the browser size to see the chart

What is TPTX (Turning Point Therapeutics) average time for price targets to be met?

On average it took 77.08 days on average for the stock forecasts to be realized with a an average price target met ratio 58.39

Which analyst has the current highest performing score on TPTX (Turning Point Therapeutics) with a proven track record?

JIM BIRCHENOUGH

Which analyst has the most public recommendations on TPTX (Turning Point Therapeutics)?

Jim Birchenough works at WELLS FARGO and has 10 price targets and 4 ratings on TPTX

Which analyst is the currently most bullish on TPTX (Turning Point Therapeutics)?

Zegbeh Jallah with highest potential upside - $98.99

Which analyst is the currently most reserved on TPTX (Turning Point Therapeutics)?

Bradley Canino with lowest potential downside - -$31.01

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?